Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
POLA2
Introduction
Polymerase (DNA directed), alpha 2 (70kD subunit), also known as POLA2, is a human gene.[1]
Further reading
Further reading
- Pollok S, Stoepel J, Bauerschmidt C; et al. (2003). “Regulation of eukaryotic DNA replication at the initiation step”. Biochem. Soc. Trans. 31 (Pt 1): 266–9. doi:10.1042/ Check
|doi=value (help). PMID 12546699. - Nasheuer HP, Moore A, Wahl AF, Wang TS (1991). “Cell cycle-dependent phosphorylation of human DNA polymerase alpha”. J. Biol. Chem. 266 (12): 7893–903. PMID 1902230.
- Collins KL, Russo AA, Tseng BY, Kelly TJ (1993). “The role of the 70 kDa subunit of human DNA polymerase alpha in DNA replication”. EMBO J. 12 (12): 4555–66. PMID 8223465.
- Dantzer F, Nasheuer HP, Vonesch JL; et al. (1998). “Functional association of poly(ADP-ribose) polymerase with DNA polymerase alpha-primase complex: a link between DNA strand break detection and DNA replication”. Nucleic Acids Res. 26 (8): 1891–8. PMID 9518481.
- Schneider A, Smith RW, Kautz AR; et al. (1998). “Primase activity of human DNA polymerase alpha-primase. Divalent cations stabilize the enzyme activity of the p48 subunit”. J. Biol. Chem. 273 (34): 21608–15. PMID 9705292.
- Huang D, Jokela M, Tuusa J; et al. (2001). “E2F mediates induction of the Sp1-controlled promoter of the human DNA polymerase epsilon B-subunit gene POLE2”. Nucleic Acids Res. 29 (13): 2810–21. PMID 11433027.
- Taneja P, Gu J, Peng R; et al. (2002). “A dominant-negative mutant of human DNA helicase B blocks the onset of chromosomal DNA replication”. J. Biol. Chem. 277 (43): 40853–61. doi:10.1074/jbc.M208067200. PMID 12181327.
- Strausberg RL, Feingold EA, Grouse LH; et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T; et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Lehner B, Sanderson CM (2004). “A protein interaction framework for human mRNA degradation”. Genome Res. 14 (7): 1315–23. doi:10.1101/gr.2122004. PMID 15231747.
- Beausoleil SA, Jedrychowski M, Schwartz D; et al. (2004). “Large-scale characterization of HeLa cell nuclear phosphoproteins”. Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. doi:10.1073/pnas.0404720101. PMID 15302935.
- Gerhard DS, Wagner L, Feingold EA; et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
- Stelzl U, Worm U, Lalowski M; et al. (2005). “A human protein-protein interaction network: a resource for annotating the proteome”. Cell. 122 (6): 957–68. doi:10.1016/j.cell.2005.08.029. PMID 16169070.
- Rual JF, Venkatesan K, Hao T; et al. (2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
- Beausoleil SA, Villén J, Gerber SA; et al. (2006). “A probability-based approach for high-throughput protein phosphorylation analysis and site localization”. Nat. Biotechnol. 24 (10): 1285–92. doi:10.1038/nbt1240. PMID 16964243.